<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01483443</url>
  </required_header>
  <id_info>
    <org_study_id>GIRBA2263</org_study_id>
    <nct_id>NCT01483443</nct_id>
  </id_info>
  <brief_title>Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients</brief_title>
  <official_title>Prophylactic Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Patients With or Without Ovarian Metastasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gachon University Gil Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective phase III trial to define the role of oophorectomy in metastatic
      colorectal cancer patients with ovarian metastasis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A recent study demonstrated that colorectal cancer with ovarian metastases were less
      responsive to chemotherapy compared to extraovarian metastases. The survival impact of
      oophorectomy has not been defined yet in this clinical setting. The incidence of microscopic
      ovarian metastasis has been reported to be approximately 10%. Therefore, the investigators
      propose a prospective study of oophorectomy followed by standard chemotherapy versus standard
      chemotherapy alone to determine whether oophorectomy increases survival.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Stage IV Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Oophrectomy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient undergone oophrectomy along with primary tumor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without oophrectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient group without oophrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oophrectomy</intervention_name>
    <description>Both oophrectomy</description>
    <arm_group_label>Oophrectomy group</arm_group_label>
    <other_name>No other intervention needed</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age â‰¥ 18

          2. histologically confirmed adenocarcinoma of colon

          3. documented ovarian metastasis in CT or MRI or PET-CT

          4. advanced (stage IV), metastatic, or recurrent

          5. ECOG performance status of 0~2

          6. adequate marrow, hepatic, renal and cardiac functions

          7. no prior surgical treatment to ovary

          8. provision of a signed written informed consent

        Exclusion Criteria:

          1. patient who refuses oophorectomy

          2. medical condition in which surgery cannot be tolerated Any waiver of these inclusion
             and exclusion criteria must be approved by the investigator on a case-by case basis
             prior to enrolling the subject. This must be documented by the investigator. No
             subject will be allowed to enroll in this study more than once.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won-Suk Lee, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gachon Univ. GIl Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Won-Suk Lee</name>
      <address>
        <city>Incheon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol. 2004 Apr;93(1):87-91.</citation>
    <PMID>15047218</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2011</study_first_submitted>
  <study_first_submitted_qc>November 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2011</study_first_posted>
  <last_update_submitted>August 28, 2015</last_update_submitted>
  <last_update_submitted_qc>August 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University Gil Medical Center</investigator_affiliation>
    <investigator_full_name>Won-Suk Lee</investigator_full_name>
    <investigator_title>Assistant Prof</investigator_title>
  </responsible_party>
  <keyword>oophrectomy</keyword>
  <keyword>survival</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

